26EHSPMCLMPNDLRFA: RFA for Fee-for-Service Claims for Pen Needles

The Executive Office of Health and Human Services (EOHHS) of the Commonwealth of Massachusetts has issued a Request for Applications (RFA) for rebate agreements from manufacturers of pen needles to be dispensed to MassHealth members and Health Safety Net (HSN) patients through fee-for-service and managed care delivery systems. The primary deliverable is the provision of rebates on pen needle products identified by specific National Drug Code (NDC) numbers, with rebates calculated using a Guaranteed Net Unit Price (GNUP) formula derived from Wholesale Acquisition Cost (WAC) minus the rebate amount, with separate pricing tiers for exclusive basis, dual basis, one of many, and non-preferred designations. Manufacturers must submit completed responses including a signed State Rebate Agreement with specific rebate offers by NDC by March 27, 2026, at 5:00 PM via email to EOHHS-Procurement@mass.gov. The initial contract term is 24 months, beginning January 1, 2027, and ending December 31, 2028, with potential extensions for up to three additional years in increments at EOHHS's discretion. Required qualifications include prior experience as a preferred pen needle manufacturer for Medicaid programs within the past five years, with evaluation criteria also encompassing clinical benefits, proposed GNUP pricing inclusive of managed care entity claims, compliance with response requirements, and other best value factors. The evaluation committee will assess all proposals using these best value considerations, with price serving as one factor but not the sole determinant in selection; EOHHS reserves the right to select one or more manufacturers, request best and final offers, negotiate proposal changes, and reject bids at any time during evaluation. In calendar year 2024, approximately 40,560 fee-for-service claims and 36,370 managed care entity claims for pen needles were submitted, representing approximately 34,220 total unique members or patients.

The procurement documents provided do not explicitly identify any set-aside designations for disadvantaged enterprises, minority-owned businesses, women-owned businesses, or other socioeconomic classifications, nor do they reference incumbent vendors or current contractors. There are no noted restrictions on the types of organizations that may respond, though manufacturers must be capable of maintaining a published WAC with First Data Bank or another national price compendium and providing customer service support and training to MassHealth and HSN providers. Manufacturers are responsible for ensuring covered pen needles are available to MassHealth and HSN providers at prices below WAC and must submit rebates quarterly within 38 days of receiving invoices from EOHHS, with invoices submitted within 60 days of each calendar quarter's end. The procurement documents do not specify explicit award values or budget ranges; however, the rebate structure is tied directly to utilization data and GNUP pricing calculations across three distinct payer segments: fee-for-service MassHealth members, HSN patients, and managed care entity members. EOHHS retains broad discretionary authority to modify any agreement provision, amend terms to reflect changes in policy or regulatory requirements, secure additional rebate agreements with competing manufacturers, and terminate the agreement without cause upon 30 days' notice.